Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma

In patients who had undergone stem-cell transplantation, lenalidomide maintenance therapy improved progression-free and overall survival, though at the expense of some increased hematologic toxicity and second malignant tumors. A goal of therapy for multiple myeloma, to induce complete remission and...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	The New England journal of medicine Ročník 366; číslo 19; s. 1770 - 1781
Hlavní autori:	McCarthy, Philip L, Owzar, Kouros, Hofmeister, Craig C, Hurd, David D, Hassoun, Hani, Richardson, Paul G, Giralt, Sergio, Stadtmauer, Edward A, Weisdorf, Daniel J, Vij, Ravi, Moreb, Jan S, Callander, Natalie Scott, Van Besien, Koen, Gentile, Teresa, Isola, Luis, Maziarz, Richard T, Gabriel, Don A, Bashey, Asad, Landau, Heather, Martin, Thomas, Qazilbash, Muzaffar H, Levitan, Denise, McClune, Brian, Schlossman, Robert, Hars, Vera, Postiglione, John, Jiang, Chen, Bennett, Elizabeth, Barry, Susan, Bressler, Linda, Kelly, Michael, Seiler, Michele, Rosenbaum, Cara, Hari, Parameswaran, Pasquini, Marcelo C, Horowitz, Mary M, Shea, Thomas C, Devine, Steven M, Anderson, Kenneth C, Linker, Charles
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States Massachusetts Medical Society 10.05.2012
Predmet:	Adult Aged Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use Autografts Cancer Cancer therapies Clinical trials Disease-Free Survival Double-Blind Method Female Follow-Up Studies Humans Immunotherapy Lenalidomide Maintenance Chemotherapy Male Middle Aged Multiple myeloma Multiple Myeloma - drug therapy Multiple Myeloma - mortality Multiple Myeloma - therapy Neoplasms, Second Primary - epidemiology Stem Cell Transplantation Targeted cancer therapy Thalidomide - adverse effects Thalidomide - analogs & derivatives Thalidomide - therapeutic use Toxicity Transplants & implants
ISSN:	0028-4793, 1533-4406, 1533-4406
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!